Brad Smith and Madison Mills take a closer look at some of today's trending tickers. United Healthcare (UNH) stock plunges after the company's earnings missed analyst estimates and guidance fell short. D.R. Horton (DHI) cut its 2025 outlook, citing a slow spring selling season hitting the homebuilder. Hermès (RMS.PA) will raise prices in the US to pass the tariff costs on to the consumer. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. Video Transcript 00:00 Speaker A It's now time for some of today's trending tickers. We're watching United Health, DR Horton and Hermes. First up, United Health shares plunging after the health insurer slashed its earnings forecast for the year, citing rising costs that took the company by surprise. United Health's warnings about rising costs also weighed on rival health insurers like Humana and Edna owner CVS. United Health is the largest seller of Medicare Advantage plans and saw care activity rise more than expected during the quarter. That division was also impacted by Medicare payment changes the government made to crack down on insurers. Shares down 16%. 00:51 Speaker B And next up, home builder DR Horton cutting its full-year revenue outlook as it grapples with a muted spring selling season and weak economic backdrop. The company's executive chairman said would-be buyers are more cautious, given affordability constraints and declining consumer confidence. Both revenue and earnings per share falling short of estimates in the company's fiscal second quarter. DR Horton closed roughly 19,200 homes during its most recent quarter. That is a 15% decline from the same period a year ago. 01:38 Speaker B And finally here. Oh, Brad, go ahead. 01:42 Speaker A Hermes says it will raise prices in the US to offset the impact of President Trump's tariffs, as a global trade war intensifies. The luxury brand's first quarter results were dented by weakness in the greater China market. Total sales rose 7.2% on an annual basis, just shy of analyst expectations. Earlier this week, Hermes overtook LVMH as the world's most valuable luxury group by market cap, after LVMH's weak quarter sank the stock. You can scan the QR code below to track the best and worst performing stocks of the session with Yahoo Finances trending tickers page. Related Videos 01:03 Charles Schwab, Ford, Microsoft: Trending Tickers Yahoo Finance Video • 9 minutes ago 02:38 Eli Lilly stock soars on positive weight-loss pill results Yahoo Finance Video • 20 minutes ago 01:55 American Express earnings: Key takeaways from Q1 results Yahoo Finance Video • 52 minutes ago 04:47 Is a recession looming? Here's what strategists are watching Yahoo Finance Video • 1 hour ago View Comments
UnitedHealthcare, D.R. Horton, Hermès: Trending Tickers
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...